Skip to main content
Black Rose Industries Ltd logo

Black Rose Industries Ltd — Investor Relations & Filings

Ticker · BLACKROSE ISIN · INE761G01016 LEI · 335800DXOCHG9LIZ4W64 BSE.NS Manufacturing
Open in API
Filings indexed 694 across all filing types
Latest filing 2019-11-01 Regulatory Filings
Country IN India
Listing BSE.NS BLACKROSE

About Black Rose Industries Ltd

https://www.blackrosechemicals.com

Black Rose Industries Ltd is a specialty chemical company engaged in the manufacturing and distribution of performance chemicals. The company operates a large-scale acrylamide manufacturing facility utilizing advanced biocatalytic technology to produce high-purity monomeric acrylamide. Its product portfolio includes polyacrylamides, ceramic binders, and specialty chemicals tailored for applications in water treatment, pulp and paper, textiles, and oil and gas exploration. Beyond its manufacturing operations, the company acts as a strategic distribution partner for several global chemical producers, providing technical sales and supply chain management. The company emphasizes sustainable chemical processes and maintains rigorous quality standards to serve diverse industrial sectors across domestic and international markets.

Recent filings

Filing Released Lang Actions
BLACK ROSE INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve the unaudited standalone ....
Regulatory Filings Classification · 95% confidence The document is a letter dated November 1, 2019, addressed to the stock exchange (BSE Limited) informing about a forthcoming Board of Directors meeting scheduled for November 12, 2019. The purpose of the meeting is to consider and approve unaudited standalone and consolidated financial results for the quarter ended September 30, 2019. The letter also mentions the closure of the trading window in accordance with insider trading regulations. The document does not contain the financial results themselves but is an announcement of the upcoming board meeting and the expected approval of quarterly financial results. The document length is short (1411 characters), and it serves as a notification rather than a report containing financial data. Therefore, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement about the board meeting and financial results approval schedule, not the actual interim report or earnings release.
2019-11-01 English
The company submits a certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 30th September, 2019.
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, related to share transfer deeds and compliance for the half year ended September 30, 2019. It is a compliance certificate issued by a company secretary firm, confirming procedural adherence rather than a full financial report or announcement. The document length is under 5,000 characters and it is primarily a certification letter. According to the Certification Rule, such officer certifications or attestations should be classified as Regulatory Filings (RNS).
2019-10-15 English
Certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, certifying that share transfer activities are maintained by the Registrar and Share Transfer Agents for the period April 1, 2019 to September 30, 2019. It is a compliance certification letter addressed to the stock exchange, not a financial report or detailed filing. The document length is short (1266 characters) and it primarily serves as an officer certification related to regulatory compliance. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2019-10-10 English
The Company submits to the Exchange letter informing commencement of commercial production of polyacrylamide liquids for the information of all the stakeholders of the company.
Regulatory Filings Classification · 95% confidence The document is an announcement dated October 8, 2019, informing stakeholders about the commencement of commercial production of polyacrylamide liquids. It references compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is a brief operational update rather than a financial report, management change, or other specific filing type. It does not contain financial statements, voting results, or executive changes. Given the nature of the announcement and its brevity (1788 characters), it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2019-10-08 English
The Company uploads a certificate under Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018 for the quarter ended 30th September, 2019 as received from Satellite ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018, for the quarter ended 30th September 2019. It is issued by the Registrar and Share Transfer Agents to the company and confirms the dematerialization of physical share certificates. The document is a compliance certificate related to share transfer and dematerialization, not a financial report or management discussion. It is short (2496 characters) and serves as a regulatory compliance filing rather than a report or announcement of financial results or corporate governance changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2019-10-07 English
We wish to inform you that the Trading Window for dealing in securities of the Company shall be closed for the Company's Directors / Officers and Designated Employees of the Company and ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the closure of the trading window for insiders due to upcoming financial results announcement. It references SEBI regulations and mentions the period of closure until the declaration of financial results for the quarter and half year ended September 30, 2019. There is no actual financial data or detailed report content included. The document is essentially an announcement related to insider trading restrictions ahead of financial results, not the results or report itself. The length is short (1367 characters), and it serves as a regulatory compliance notice. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than a financial report or earnings release.
2019-09-30 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.